Hennion & Walsh Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$750K	Sell	793,400 -36,654	-4%	-$34.7K	0.03%	561
2025 Q1	$382K	Sell	830,054 -33,201	-4%	-$15.3K	0.02%	708
2024 Q4	$638K	Buy	863,255 +132,117	+18%	+$97.6K	0.03%	572
2024 Q3	$1.15M	Buy	731,138 +188,239	+35%	+$296K	0.05%	417
2024 Q2	$912K	Buy	+542,899	New	+$912K	0.05%	446